Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

20111,222 citationsJournal Articlegreen Open Access

Authors

Walter J. Curran · RTOG Foundation

Rebecca Paulus · National Cancer Center

Corey J. Langer · Henry Ford Hospital

R. Komaki · Emory University

Jong Seok Lee · The University of Texas MD Anderson Cancer Center

Stephen L. Hauser · National Cancer Center

B. Movsas ·

Abstract

Concurrent delivery of cisplatin-based chemotherapy with TRT confers a long-term survival benefit compared with the sequential delivery of these therapies.

Topics & Keywords

Lung Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations Hepatocellular Carcinoma Treatment and Prognosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JNCI Journal of the National Cancer Institute

Volume 103, Issue 19, pp. 1452-1460

DOI: 10.1093/jnci/djr325

Field-Weighted Citation Impact: 50.74